The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $29.51

Today's change+0.61 +2.13%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.
 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $29.51

Today's change+0.61 +2.13%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

Sabra Health Care REIT Inc Hits New 20-day High

Sabra Health Care REIT Inc closed up sharply Friday, rallying (U.S.)$0.61 or 2.13% to (U.S.)$29.51 and setting a new 20-day high. Over the last five days, shares have gained 2.47% and 12.89% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $29.00
  • Previous close(U.S.) $28.90
  • High(U.S.) $29.56
  • Low(U.S.) $28.86
  • Bid / Ask(U.S.) $25.00 / (U.S.) $38.00
  • YTD % change+12.89%
  • Volume1,369,171
  • Average volume (10-day)1,041,177
  • Average volume (1-month)676,013
  • Average volume (3-month)802,426
  • 52-week range(U.S.) $24.01 to (U.S.) $31.17
  • Beta1.20
  • Trailing P/E49.48×
  • P/E 1 year forward37.04×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.56
  • Dividend yield5.29%
  • Trailing EPS(U.S.) $0.60
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue44434138
Total other revenue--------
Total revenue44434138
Gross profit--------
Total cost of revenue--------
Total operating expense27294824
Selling / general / administrative6865
Research & development--------
Depreciation / amortization101099
Interest expense (income), net operating11111111
Unusual expense (income)00220
Other operating expenses, total--------
Operating income1714-813
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1715-713
Income after tax1715-713
Income tax, total0000
Net income1715-713
Total adjustments to net income-3-3-3-3
Net income before extra. items1715-713
Minority interest000--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1512-1010
Inc. avail. to common incl. extra. items1512-1010
Diluted net income1512-1010
Dilution adjustment0000
Diluted weighted average shares48443939
Diluted EPS excluding extraordinary itemsvalue per share0.310.28-0.250.27
Dividends per sharevalue per share0.380.380.360.34
Diluted normalized EPSvalue per share0.310.280.310.27